CFTR Modulators in Pregnancy and Postpartum

Sponsor
Region Stockholm
Study ID
NCT06302270
Status
Recruiting
Apply to this trial

Conditions

  • Cystic Fibrosis

Eligibility Criteria

Sex
ALL
Age
N/A - 50 Years
Healthy Volunteers
Not accepted

Study Details

Observational study on women with Cystic Fibrosis treated with CFTR modulators during pregnancy and postpartum and their children. Registration on maternal health parameters and effects of CFTR-modulators in the newborn infant as well as effects of exposure through mother's own milk.

Key Dates

First listed
Mar 8, 2024
Start date
Mar 15, 2024
Status verified
Mar 2024
Primary completion
Jan 31, 2034
Completion
Jan 31, 2039

Study Design

Enrollment
75 participants (estimated)

Arms

  • Arm: mother-infant dyads

Primary Outcome Measure

Health effects in the newborn infant [ Time Frame: 6 years ]

Central Contacts

Related Studies